Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

HPV vax worth including in Brazilian immunisation programme

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    HPV vax worth including in Brazilian immunisation programme. Pharmacoecon. Outcomes News 657, 9 (2012). https://doi.org/10.2165/00151234-201206570-00023

    Download citation

    Keywords

    • Human Papilloma Virus
    • Cost Effectiveness Ratio
    • Incremental Cost Effectiveness Ratio
    • Vaccination Strategy
    • Immunisation Programme